The conserved GTPase Nug2/Nog2 (Extended Data Fig. 1) is associated with a number of pre-60S particles located in the nucleoplasm, but was not detected on particles with a known cytoplasmic location (see also Extended Data Fig. 2). The bacterial homolog of Nug2, YlqF, binds directly to rRNA^[@R11]^, and we therefore used the CRAC UV cross-linking method to localize the binding site for yeast Nug2 within the pre-60S particle^[@R12]^. Direct contacts for Nug2 were identified only with the 25S rRNA, at sites in helices H38, H69, H71, H80, H81-83, H84-86, H89, H91-92 and H93 ([Fig. 1a, c](#F1){ref-type="fig"}). Yeast 3-hybrid analyses confirmed interactions between Nug2 and these rRNA helices ([Fig. 1b](#F1){ref-type="fig"}). Mapping the major rRNA crosslink sites of Nug2 onto the 60S subunit structure ([Fig. 1d](#F1){ref-type="fig"}) showed a distinct cluster on the inter-subunit joining surface^[@R13]^. Nug2 binding sites overlap with regions occupied by the export factor Nmd3 in cryo-EM^[@R10]^. CRAC was therefore applied to Nmd3 to more precisely identify its binding sites, which were found to lie in H38, H69 and H89 of 25S rRNA ([Fig. 1a, c, e](#F1){ref-type="fig"}). Strikingly, the Nug2 and Nmd3 binding sites overlapped in H38, H69 and H89 ([Fig. 1c, f](#F1){ref-type="fig"}), suggesting that binding of these two proteins is mutually exclusive. To test this, pre-60S particles were purified with tagged Nug2 and shown to lack detectable Nmd3, and *vice versa* (Extended Data Fig. 2). Nmd3 is an essential nuclear export factor that recruits the export receptor Crm1 to the nascent 60S subunits^[@R14],[@R15]^. These observations suggested that Nug2 acts as a "placeholder" to prevent premature recruitment of Nmd3 to earlier, export-incompetent pre-60S particles.

Like other GTP-binding proteins, Nug2 has characteristic G1, G3 and G4 motifs in its G-domain ([Fig. 2a](#F2){ref-type="fig"}, Extended Data Fig. 1), suggesting that GTP-binding or hydrolysis^[@R16]^ might regulate dynamic interactions between Nug2 and the pre-ribosome. Dominant-negative mutations were previously described in two GTPases involved in ribosome biogenesis, the G1-motif of Lsg1 (K349N/R/T)^[@R17]^ and G3-motif of Nog1 (G224A)^[@R18]^. Orthologous G1- and G3-motif mutants, *nug2K328R* and *nug2G369A*, respectively ([Fig. 2a](#F2){ref-type="fig"}, Extended Data Fig. 1), each showed severe growth defect phenotypes ([Fig. 2b](#F2){ref-type="fig"}), and were also dominant-negative when overexpressed in the presence of chromosomal *NUG2* ([Fig. 2c](#F2){ref-type="fig"}). Pre-ribosome analysis by sucrose gradient centrifugation showed that the Nug2K328R and Nug2G369A proteins were efficiently assembled into pre-60S subunits, but induced a 'half-mer' polysome phenotype (in particular for Nug2K328R), characteristic of reduced 60S subunit synthesis ([Fig. 2d](#F2){ref-type="fig"}). The reduced 60S levels were more apparent under low Mg^2+^ conditions that cause 80S ribosomes to dissociate into 60S and 40S subunits ([Fig. 2d](#F2){ref-type="fig"}). The *nug2K328R* and *nug2G369A* strains showed nuclear accumulation of a RpL25-GFP reporter, but not RpS3-GFP, revealing a specific block in pre-60S nuclear export ([Fig. 2e](#F2){ref-type="fig"}). We conclude that mutations in the GTPase domain of Nug2 allow recruitment to the pre-ribosomes, but block nuclear export.

To determine the basis of the defects associated with Nug2K328R and Nug2G369A, we assayed *in vitro* guanine nucleotide-binding activity and GTP hydrolysis. Nug2 from *Saccharomyces cerevisiae* was unstable when expressed in *E.coli* (data not shown). In contrast, good yields were obtained for wild-type and mutant Nug2 from the eukaryotic thermophile *Chaetomium thermophilum* (*ct*Nug2, *ct*Nug2K339R and *ct*Nug2G380A, respectively; [Fig. 2f](#F2){ref-type="fig"}), whose thermostable proteins have superior biochemical properties^[@R19]^. *ct*Nug2 is highly homologous to yeast Nug2 (74% identity; Extended Data Fig. 1), and can complement albeit not perfectly a yeast *nug2*Δ mutant (Extended Data Fig. 3). As Nug2 may act as a potassium-dependent GTPase^[@R20]^, we tested the cation requirement for GTP hydrolysis. The GTPase activity of *ct*Nug2 was low in NaCl-containing buffer, but was substantially stimulated by KCl ([Fig. 2f](#F2){ref-type="fig"}). In contrast, *ct*Nug2K339R and *ct*Nug2G380A exhibited only background GTPase activity ([Fig. 2f](#F2){ref-type="fig"}). In binding assays, wild-type *ct*Nug2 and *ct*Nug2G380A readily bound fluorescent MANT-GTP or MANT-GDP, whereas *ct*Nug2K339R did not ([Fig. 2g](#F2){ref-type="fig"}). We conclude that *ct*Nug2K339R is defective in GTP binding, whereas *ct*Nug2G380A binds but cannot hydrolyse GTP. This K^+^-stimulated GTPase activity might regulate interaction of Nug2 with nascent 60S particles.

Nug2 is associated with nucleoplasmic pre-60S particles that also carry the Rix1-Ipi1-Ipi3 heterotrimer, the dynein-related AAA-ATPase Rea1 and its co-substrate Rsa4 (Extended Data Fig. 2; see also below and[@R21]). The enzymatic activity of Rea1 is required for the release of Ytm1^[@R22]^ and Rsa4^[@R21]^ and a genetic screen revealed synthetic lethality between the G1-motif mutant *nug2K328R* and the mutant alleles *rea1-DTS and rsa4-1*^[@R21]^ ([Fig. 3a](#F3){ref-type="fig"}). We therefore investigated whether ATP-dependent remodeling of the Rix1-particle by the AAA-ATPase activity of Rea1^[@R21]^ is altered in particles containing Nug2K328R or Nug2G369A. Pre-60S particles carrying Flag-tagged RpL3 were affinity-purified with Rix1-TAP via IgG binding and TEV elution. The pre-60S particles were incubated *in vitro* to allow factor release, and then re-isolated on Flag-beads via RpL3-Flag ([Fig. 3b](#F3){ref-type="fig"}). Consistent with previous data^[@R21]^, incubation of the pre-60S particles with ATP in Na^+^-containing buffer resulted in release of Rsa4 and Rea1, but not Nug2 ([Fig. 3c](#F3){ref-type="fig"}). In contrast, incubation in K^+^-containing buffer caused the ATP-dependent release of Nug2, in addition to Rsa4 and Rea1 ([Fig. 3c](#F3){ref-type="fig"}). Incubation with GTP in Na^+^ or K^+^-containing buffer did not induce the release of biogenesis factors ([Fig. 3d](#F3){ref-type="fig"}). However, neither Nug2K328R nor Nug2G369A could be dissociated from pre-60S particles upon ATP treatment in K^+^ buffer ([Fig. 3e](#F3){ref-type="fig"}). In the case of Nug2K328R (defective in GTP-binding), incubation with ATP in K^+^ buffer failed to release Rsa4, whereas pre-60S particles carrying Nug2G369A (defective in GTP-hydrolysis) still showed Rsa4 release upon ATP-treatment ([Fig. 3e](#F3){ref-type="fig"}). Mutation of one of the six ATP-binding protomers of Rea1 (AAA2; *rea1* K659A) inhibited remodeling, including Nug2 release (Extended Data Fig. 4). These findings indicate that the GTP-binding activity of Nug2 influences the remodeling activity of the Rea1 ATPase, whereas GTP hydrolysis is necessary for the final Nug2 release from the pre-60S subunit.

*In vitro*, Rea1-dependent release of Rsa4 and Nug2 required only ATP and K^+^ without addition of GTP, whereas the mutational analyses suggested that GTPase activity is necessary for Nug2 release. These findings suggest that Nug2 on the Rix1-particle might have retained bound GTP during purification (which is possible due to its low intrinsic GTPase activity). Alternatively, ribosome-associated nucleotide diphosphate kinases can transfer the γ-phosphate from ATP to GDP to generate GTP-loaded GTPases^[@R23],[@R24]^.

The pre-60S particles co-purified with Rix1 also contained small amounts of Ytm1 and Erb1 ([Fig. 3c](#F3){ref-type="fig"}), which were previously described as nucleolar co-substrates for Rea1^[@R22]^, and both were released by incubation with ATP in Na^+^ or K^+^ buffer ([Fig. 3c](#F3){ref-type="fig"}).

To determine the step in 60S subunit biogenesis at which dissociation of Nug2 is disturbed *in vivo*, we affinity-purified different pre-60S particles from Nug2 wild-type and mutant cells using bait proteins that specifically enrich nucleolar, nucleoplasmic or cytoplasmic intermediates ([Fig. 4a](#F4){ref-type="fig"}). The *nug2K328R* mutation did not markedly alter the biochemical composition of most pre-60S particles tested. The exception was Arx1-associated particles, which showed a marked depletion of the export adapter Nmd3 and the cytoplasmic factor Rei1 that stimulates recycling of Arx1^[@R25]^ ([Fig. 4a](#F4){ref-type="fig"}). Nmd3 was also largely absent from Arx1-particles purified from *nug2*G369A cells ([Fig. 4b](#F4){ref-type="fig"}).

To test the model that Nug2 depletion allows premature recruitment of Nmd3 we employed an auxin-inducible degron system^[@R28]^. Nug2 was expressed as a fusion protein (sAid-Nug2-sAid) with two copies of the sAid tag (small Auxin-inducible degron), which is targeted by the F-box E3 ubiquitin ligase TIR1 in the presence of auxin, inducing fast proteasomal degradation^[@R28]^ (Extended Data Fig. 5). Nmd3 is normally not detected on Rix1-associated particles, but was prematurely recruited to this pre-60S particle upon Nug2 depletion ([Fig. 4c](#F4){ref-type="fig"}). Concomitant with Nmd3 association, the recovery of Rea1 and Rsa4 decreased during Nug2 depletion ([Fig. 4c](#F4){ref-type="fig"}). We conclude that Nug2 promotes the stable association of Rsa4 and Rea1 with the Rix1-particles, while blocking premature recruitment of Nmd3.

To address the timing of Nug2 recruitment to pre-60S particles in comparison to Rea1, Rsa4 and the Rix1-Ipi1-Ipi3 complex, we employed a combination of affinity-purification and immunodepletion. Affinity-purification of Nug2-TAP yielded a mixture of different pre-60S particles including Rix1/Rea1-particles. Rix1-FLAG immunoprecipitation was used to deplete Rix1/Rea1-particles from this mixture, leaving Nug2 particles that contained Rsa4 and a number of intermediate pre-60S factors including Nog1, Arx1, Nug1, Nop53, Nsa3, Rpf2, Rlp7 and Nsa2, ([Fig. 4d](#F4){ref-type="fig"}). However, this Nug2-particle lacked other (further upstream) pre-60S factors such as Ytm1, Erb1 and Has1, suggesting that it corresponds to the precursor particle to which Nug2 was recruited. These data complement previous findings that Nog2/Nug2 is the last "B-factor" to associate with pre-ribosomes after dissociation of Has1^[@R29]^.

As outlined in [Fig. 4e](#F4){ref-type="fig"}, we propose that a previously uncharacterized step in the reorganization of the evolving pre-60S subunit primes it for nuclear export. This involves a regulatory GTPase Nug2 that overlaps with the binding site for the essential nuclear export adaptor Nmd3. As long as intranuclear maturation is incomplete, the pre-60S subunit cannot be exported, since recruitment of this essential export factor is not possible. However, a late nucleoplasmic remodeling step, catalyzed by the AAA-ATPase Rea1 and its co-factor Rsa4, restructures the pre-60S particle, which could lead to both an rRNA and assembly factor rearrangement. This conformational change could also stimulate Nug2's K^+^-dependent GTPase activity, thereby triggering its release from the matured pre-60S particles. We suggest that the Nug2 GTPase acts as molecular switch to proofread pre-ribosome maturation and regulate the acquisition of export competence. After this reorganization step, the binding site for Nmd3 becomes accessible on the pre-60S subunit, which further triggers Crm1 and RanGTP recruitment to generate nuclear export competence. Thus, our data indicate coordination between a remodeling AAA-ATPase and a conformation-sensing GTPase.

The human Nug2 orthologue Gnl2 is highly expressed in proliferating cells including cancer cells and involved in the control of cell cycle progression^[@R30]^. The discovery of the role of Nug2 during surveillance of ribosome biogenesis may help reveal the molecular mechanisms by which nucleostemin family members interconnect the elementary cellular processes of ribosome biogenesis and cell proliferation.

METHODS {#S2}
=======

Yeast strains and genetic methods {#S3}
---------------------------------

The *S. cerevisiae* strains used in this study are listed in Extended Data Table 1. Gene disruption and C-terminal tagging were performed as previously described^[@R31],[@R32]^.

Plasmid constructs {#S4}
------------------

All recombinant DNA techniques were performed according to standard procedures using *Escherichia coli* DH5α for cloning and plasmid propagation. Site-directed mutagenesis was performed by overlap-extension PCR. All cloned DNA fragments generated by PCR amplification were verified by sequencing. Plasmids used in this study are listed in Extended Data Table 2.

CRAC analysis {#S5}
-------------

The CRAC experiments were performed as described^[@R12]^ using the Nug2- and Nmd3-HTP (His~6~-TEV-ProtA) strain. CRAC data were processed using pyCRAC (Webb, Hector, Kudla and Granneman, in preparation). Cells were UV-irradiated in the Megatron UV chamber^[@R1]^ at a dose of 1.6J/cm^2^ and processed as described^[@R12],[@R33]^. The cDNAs from the Nug2 CRAC data were cloned into pCR4-TOPO (Invitrogen) and inserts were sequenced by Sanger sequencing. The cDNAs originating from Nmd3 CRAC experiments were sequenced on the Illumina MiSeq system (single-end 50b), according to manufacturers procedures. The MiSeq CRAC data were processed using the pyCRAC software suite (Webb, Hector, Kudla and Granneman, submitted; <https://bitbucket.org/sgrann/pycrac>). To remove potential PCR duplicates, the Nmd3 MiSeq data was collapsed using pyFastqDuplicateRemover. Reads subsequently mapped to the yeast genomic reference sequence (version 2008) using novoalign ([www.novocraft.com](http://www.novocraft.com)). Plots of reads aligned to the 35S reference sequence were generated using pyPileup and GNUplot. Adapters using this experiment are listed in Extended Data Table 3.

Expression and purification of *ct*Nug2 {#S6}
---------------------------------------

The gene encoding *Chaetomium thermophilum* Nug2 (accession number in the UniProtKB/TrEMBL protein data base: G0SBX1_CHATD) was cloned from cDNA by standard procedures as recently described^[@R19]^. Subsequently, the *ct*Nug2 was inserted into yeast or *E. coli* expression plasmids (see below). Since the C-terminal extension of *ct*Nug2 (511 - 627 aa) is not conserved (Extended Data Fig. 1), *ct*Nug2 from 1 to 510 amino acids was cloned into pET21 vector for the *in vitro* experiments. *ct*Nug2 was expressed by using pET-ctNug2-510-His~6~ plasmid in *E. coli* Rosetta-DE3 cells. Transformed cells were grown at 23°C in LB medium until reached OD of 0.6, IPTG was added to a final concentration of 0.1 mM. The cells were grown for additional 3 h and then harvested by centrifugation and stored frozen at −80°C. Frozen pellets were resuspended in buffer KCl~200~ (50 mM Tris, pH 8.0, 200 mM KCl, 5% glycerol, 0.01% NP-40, 2 mM ß-mercaptoethanol) with protease-inhibitor cocktail, and were broken by sonication (BANDELIN sonopuls 3200 with TITANTELLER TT13) on ice. Sonication was performed under these conditions: Amplitude: 50%, 3 seconds ON, 8 seconds OFF, processed for 10 minutes. The lysate was centrifuged at 18,000 rpm for 30 minutes at 4 °C. The supernatant fraction was applied to a SP-sepharose column, and it was washed with buffer KCl~200~. *ct*Nug2-His~6~ was eluted by buffer KCl~200~ containing 300mM KCl. Next, the eluate fraction was applied to Ni^2+^-NTA column, and the column was washed with buffer KCl~200~. *ct*Nug2-His~6~ was eluted by buffer KCl~200~ containing 250mM imidazole, before it was finally dialyzed against buffer KCl~200~.

Measurement of GTPase activity by single-turnover reactions {#S7}
-----------------------------------------------------------

The GTPase activity experiments were performed as previously described^[@R34]^. 1μM *ct*Nug2, *ct*Nug2K339R or *ct*Nug2G380A were incubated with a final concentration of 0.1 μM GTP containing 750 nCi of γ-P^32^-labeled GTP in buffer KCl~300~ (50 mM Tris, pH 8.0, 300 mM KCl, 10mM MgCl~2~, 1 mM DTT) or in buffer NaCl~300~ (50 mM Tris, pH 8.0, 300 mM NaCl, 10mM MgCl~2~, 1 mM DTT) for indicated time at 30°C. After the reaction, the hydrolyzed γ-phosphate was separated by thin-layer chromatography.

Guanine nucleotide binding experiments {#S8}
--------------------------------------

1μM *ct*Nug2, *ct*Nug2K339R or *ct*Nug2G380A were incubated with 0.1μM MANT-GTP or MANT-GDP in buffer KCl~300~ (50mM Tris, pH 8.0, 300mM KCl, 60mM MgCl~2~, 20mM EDTA, 1mM DTT). MANT-GTP or MANT-GDP are analogues of natural GTP or GDP, where either the ribose 2′-hydroxy or the 3′-hydroxy group has been esterified by the fluorescent methylisatoic acid with an Ex/Em = 355/448 nm. The fluorescence quantum yield of Mant fluorophore is very low in water and increases significantly in nonpolar solvents or upon binding to most proteins. This highly environmental sensitive fluorescence of Mant makes Mant-GTP/GDP useful for directly detecting the nucleotide-protein interactions. Accordingly, it was excited at 355 nm with a xenon lamp, and emission spectra were recorded between 385-600 nM with a 5 nm increment step using a Synergy 4 spectrophotometer (BioTek).

*In vitro* release assay. {#S9}
-------------------------

Rix1-particle was affinity purified using IgG beads via Rix1-TAP from yeast strain (Rix1-TAP, RpL3-Flag) expressing *NUG2, nug2K328R* and *nug2G369A* followed by TEV protease cleavage at 4°C to release the Rix1-particle. The TEV-eluate (i.e. the released Rix1-particle) was incubated with 4mM ATP or 4mM GTP at 23 °C for 1 hour. After ATP or GTP treatment, the 60S particle was re-purified via affinity purification of L3-Flag using Flag beads. Buffer KCl~100~ (50 mM Tris, pH 8.0, 100 mM KCl, 10 mM MgCl~2~, 1 mM DTT) or buffer NaCl~100~ (50 mM Tris, pH 8.0, 100 mM NaCl, 10 mM MgCl~2~, 1 mM DTT) were used. Affinity purifications were performed as previously described^[@R35]^.

Immunodepletion of Rix1 by FLAG immunoprecipitation {#S10}
---------------------------------------------------

Nug2-particle was affinity purified from yeast strain (Nug2-TAP, Rix1-Flag) via IgG beads. The TEV eluate was incubated twice with Flag beads at 4°C for 30min each to deplete the Rix1-associated Nug2 particle. The flow-through was used for the final Calmodulin purification step.

Miscellaneous {#S11}
-------------

Additional methods used in this study and previously described were TAP-purifications of pre-60S particles^[@R36]^, sucrose gradient analysis to obtain ribosomal and polysomal profiles^[@R37]^, ribosomal export assays using the large subunit reporter Rpl25-GFP monitored by fluorescence microscopy^[@R38]^ and yeast 3-hybrid analysis^[@R39]^. Antibodies used for Western analysis in the following dilutions were anti-Nug2^[@R40]^ 1:10,000, anti-Rsa4^[@R41]^ 1:10,000, anti-Nmd3^[@R15]^ 1:5,000, anti-Mex67/Mtr2^[@R42]^ 1:10,000, anti-RpL35^[@R43]^ 1:35,000, anti-RpL3^[@R44]^ 1:5000, anti-Nsa2^[@R45]^ 1:10,000, anti-RpL10^[@R46]^ 1:1000, anti-Nog1^[@R40]^ 1:30,000, anti-Rei1^[@R47]^ 1:5,000, goat-anti-mouse 1:3,000 (Cat.-No. 170-6516) and mouse-anti-rabbit horse radish peroxidase conjugated antibodies 1:3,000 (Cat.-No. 170-6515, both BIORAD, Munich, Germany). Page Ruler Unstained Protein Ladder (Thermo Scientific, Rockford, Illinois, USA) was used as a protein marker, Brillant Blue G-Colloidal Concentrate Electrophoresis Reagent (Sigma-Aldrich, Munich, Germany) was used for Coomassie stain, and 4-12% NuPAGE Bis-Tris Gels (Novex, Darmstadt, Germany) together with NuPAGE MOPS SDS Running Buffer (Invitrogen, Darmstadt, Germany) were used for SDS-PAGE.

Extended Data {#SM}
=============

We thank Drs. M. Remacha, M. Fromont-Racine, A. W. Johnson, C. Dargemont, M. Seedorf, and J. Warner for antibodies. We thank the GenePool at the University of Edinburgh for performing the MiSeq sequencing, and Elisabeth Petfalski for performing the initial cross-linking test experiments. We thank Dr. Emma Thomson for careful reading the manuscript. This work was supported by a postdoctoral fellowship from Alexander von Humboldt Foundation to Y.M., and by the Welcome Trust to S.G. and D.T. (077248), and by grants from the Deutsche Forschungsgemeinschaft to E.H. (DFG Hu363/10-4).

Reprints and permissions information is available at [www.nature.com/reprints](http://www.nature.com/reprints).

The authors declare no competing financial interests.

![Nug2 binds to inter-subunit face of the pre-60S subunit clashing with export factor Nmd3\
(**a**) CRAC analyses of Nug2 and Nmd3 (performed twice; only sites were considered that were reproducibly found in both datasets). Total number of hits was plotted against the relative location along the rDNA. (**b**) Yeast 3-hybrid revealing interaction between Nug2 and identified 25S rRNA fragments. Negative control, empty vector and H25. (**c**) Nug2 (yellow) and Nmd3 binding sites (green) identified by CRAC and highlighted in the indicated 25S rRNA. (**d, e**) Mapping of CRAC Nug2 (yellow) and Nmd3 (green) binding sites on the 60S structure (PDB: 3O5H^[@R13]^). (**f**) Overlapping binding sites (red) of Nug2 (yellow) and Nmd3 (green).](emss-55090-f0001){#F1}

![K^+^-dependent GTPase activity of Nug2\
(**a**) Domain organization of Nug2. (**b**). Complementation of *nug2*Δ cells by *NUG2, nug2K328R* and *nug2G369A* on YPD plates. (**c**) Repression (+doxycycline) and overexpression (−doxycycline) of *NUG2, nug2K328R* and *nug2G369A* in *NUG2* cells. (**d**) Polysomal (10mM MgCl~2~; upper panel) and ribosomal profiles (1.5mM MgCl~2~; lower panel) of *NUG2, nug2K328R and nug2G369A* cells analyzed by sucrose gradient centrifugation. Western analysis of gradient fractions using antibodies against Nug2 and RpL35 (upper panel) (**e**) Subcellular distribution of RpL25-GFP and RpS3-GFP in *NUG2* and *nug2* mutant cells analyzed by fluorescence microscopy. (**f**) GTPase activity of purified *ct*Nug2 (SDS-PAGE; left panel) analyzed by thin-layer chromatography/autoradiography (middle panel). Ratio of hydrolyzed phosphate/total GTP plotted against time (right panel). (**g**) Binding of MANT-GTP (left panel) and MANT-GDP (right panel) to purified wild-type and mutant *ct*Nug2. GTPase and binding assays were performed twice yielding highly reproducible datasets.](emss-55090-f0002){#F2}

![Nug2 release from pre-60S particles requires intrinsic K^+^-dependent GTPase and Rea1 ATPase activity\
(**a**) Synthetic lethality (*sl*) between alleles *rsa4-1*^[@R21]^ or *rea1-DTS*^[@R21]^ and *nug2K328R* revealed by growth on 5-FOA. (**b-e**) ATP-dependent release of Rsa4 and Nug2 from purified pre-60S particles. Scheme of the release assay (**b**) and experimental analyses (**c-e**). Affinity-purified Rix1-particles carrying wild-type or mutant Nug2 were incubated with ATP or GTP in NaCl or KCl buffer, before matured pre-60S particles were re-isolated via RpL3-Flag affinity-purification. Final eluates were analyzed by SDS-PAGE and Coomassie staining (upper panel; indicated bands were identified by mass spectrometry) and Western blotting using the indicated antibodies (lower panel). All *in vitro* assays were performed at least twice with highly reproducible datasets.](emss-55090-f0003){#F3}

![Nug2 release from the pre-60S subunit is linked to Nmd3 recruitment\
(**a**) Affinity-purification of the indicated TAP-tagged pre-60S factors from *NUG2* or *nug2K328R* mutant cells. (\*) position of Rei1 identified by mass spectrometry. (**b**) Affinity-purification of Arx1-TAP from *NUG2, nug2K328R* and *nug2G369A* cells. (**c**) Affinity-purification of Rix1-TAP from sAid-Nug2-sAid degron strain after time-dependent auxin treatment. (**d**) Affinity-purification of Nug2-TAP particles with (lane 1) or without (lane 2) subsequent Rix1-Flag immunodepletion. (**a-d**) SDS-PAGE and Coomassie staining (upper panel) and Western blotting using the indicated antibodies (lower panel). Protein bands indicated were identified by mass spectrometry. All affinity-purifications were performed at least twice, yielding highly reproducible datasets. (**e**) Model of pre-60S subunit maturation starting from the Rix1-particle with final Nmd3-Crm1-RanGTP recruitment.](emss-55090-f0004){#F4}
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